TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ZHEJIANG JINGXIN

CardiovascularNeurology
Generics

ZHEJIANG JINGXIN is a generic drug manufacturer focused on Cardiovascular, Neurology.

2010
Since
3
Drugs
-
Trials
171
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-06
Labeling
LEVETIRACETAM 2025-07-09
Labeling
ROSUVASTATIN CALCIUM 2025-05-16
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 86%
1 drugs
Neurology 14%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

GE HEALTHCARE specialty
Neurology, Cardiovascular
Novo Nordisk big-pharma
Cardiovascular, Neurology
LEDERLE big-pharma
Cardiovascular, Neurology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular
VALIDUS PHARMS specialty
Cardiovascular, Neurology